Who are Nirrin Technologies's investors?

Nirrin Technologies's investors include Anzu Partners.

How much funding has Nirrin Technologies raised?

Nirrin Technologies has disclosed $20M raised across 3 of its 4 known rounds.

Where is Nirrin Technologies headquartered?

Nirrin Technologies is headquartered in Billerica, US.

Nirrin Technologies

Billerica, US · Founded 2017 · Delaware corporation · 1 known investors

Nirrin builds optical instruments and analytics software for bioprocess teams to generate measurement data across development and manufacturing workflows. Its systems are designed for deployment in regulated biopharma production and quality environments.

Biotech Deep Tech Hardware

Founders & leadership

Bryan HassellinExecutive

Jonathan HartmannChief Executive Officer

John C. Ho in 𝕏Named on SEC filingPartner at Anzu Partners

Board

David SeldinBoard directorManaging Partner at Anzu Partners

David Michael inBoard directorManaging Partner at Anzu Partners

Matthew GunnisonBoard director

Debrah Herman inChief Financial OfficerPartner at Anzu Partners

Investors · 1

Anzu PartnersreportedBillericavia David Seldin · board

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 3 of 4 rounds · 2021–2026

▶$6.7MraisedJun 2026 · 23 investors · Biotechnology

Rule 506(b)

Nirrin Technologies has filed a notice of an exempt offering of securities to raise $9,711,196.00 in New Funding. - intelligence360intelligence360.news · Jul 2026

Officers, directors & promoters on the filing

Bryan HassellExecutive Officer
David SeldinDirector
David MichaelDirector
Matthew GunnisonDirector

Offering amount: $9.7M
Amount sold: $6.7M
Proceeds to insiders: $241K
First sale: Sep 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4.8MraisedFeb 2024 · 20 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Debrah HermanExecutive Officer
David Carr MichaelDirector
Matthew GunnisonDirector
Gregory CresenziExecutive Officer
David Michael SeldinDirector

Offering amount: $6M
Amount sold: $4.8M
First sale: Feb 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$8.5MraisedOct 2021 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David Michael SeldinExecutive Officer, Director
Debrah HermanExecutive Officer
Jonathan HartmannExecutive Officer, Director
David Carr MichaelDirector
John C. HoDirector

Offering amount: $8.5M
Amount sold: $8.5M
First sale: Oct 2021
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Therini Bio3 shared keywordsTherini Bio is a biotechnology company developing therapies that block vascular-mediated inflammation to halt chronic neurological disease. Its candidates target neuro-related conditions and are being advanced through clinical development.

Companies competing with Nirrin Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Nirrin Technologies has filed a notice of an exempt offering of securities to raise $9,711,196.00 in New Funding. - intelligence360intelligence360.news · Jul 2026

Frequently asked questions

What does Nirrin Technologies do?: Nirrin builds optical instruments and analytics software for bioprocess teams to generate measurement data across development and manufacturing workflows. Its systems are designed for deployment in regulated biopharma production and quality environments.
Who are Nirrin Technologies's investors?: Nirrin Technologies's investors include Anzu Partners.
How much funding has Nirrin Technologies raised?: Nirrin Technologies has disclosed $20M raised across 3 of its 4 known rounds.
Where is Nirrin Technologies headquartered?: Nirrin Technologies is headquartered in Billerica, US.